Featured Press Releases

MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advanced Wound Care Technologies

MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advanced Wound Care Technologies

Smart Cups Sets New Goals For Fundraising Round Amid Upcoming Partnerships And Continued Growth

Smart Cups Sets New Goals For Fundraising Round Amid Upcoming Partnerships And Continued Growth

  • 19 Jun 2024

Smart Cups, the groundbreaking sustainability-driven technology company specializing in innovative precise...

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

TIVDAK® Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

TIVDAK® Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

Automated red blood cell exchange boosts quality of life for sickle cell patients

Automated red blood cell exchange boosts quality of life for sickle cell patients

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

  • Isotopia
  • 12 Dec 2024
ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.

ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.

  • ADC Therapeutics SA
  • 11 Dec 2024
MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee

MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee

  • Petauri
  • 11 Dec 2024
Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

  • Pilatus Biosciences
  • 10 Dec 2024
Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

  • Biolexis Therapeutics Inc
  • 09 Dec 2024
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors

  • UroMems
  • 06 Dec 2024
The Precision Health Technologies Accelerator

Most Popular
December   2024
M T W T F S S
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31          

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.